KL-6 mucin expression in carcinoma of the ampulla of Vater: Association with cancer progression

World Journal of Gastroenterology

Volumn 11, Issue 35, 2005, Pages 5450-5454

  Tang, Wei ^a   Inagaki, Yoshinori ^b   Kokudo, Norihiro ^a   Guo, Qian ^a   Seyama, Yasuji ^a   Nakata, Munehiro ^b   Imamura, Hiroshi ^a   Sano, Keiji ^a   Sugawara, Yasuhiko ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Carcinoma of the ampulla of Vater; Invasion; KL 6 mucin; Metastasis; Prognosis

Indexed keywords

MUCIN; MUCIN KL 6; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM CANCER; FEMALE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; PANCREAS CANCER; PANCREATICODUODENECTOMY; PROGNOSIS; PROTEIN EXPRESSION; VATER PAPILLA CARCINOMA;

EID: 28044472238     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i35.5450     Document Type: Article

References (31)

1. Conlon KC, Dougherty E, Klimstra DS, Coit DG, Turnbull AD, Brennan MF. The value of minimal access surgery in the staging of patients with potentially respectable peripancreatic malignancy. Ann Surg 1996; 223: 134-140
2. Klempnauer J, Ridder GJ, Pichlmayr R. Prognostic factors after resection of Ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br J Surg 1995; 82: 1686-1691
3. Nakao A, Harada A, Nonami T, Kishimoto W, Takeda S, Ito K, Takagi H. Prognosis of cancer of the duodental papilla of Vater in relation to clinicopathological tumor extension. Hepato-Gasteroenterology 1994; 41: 73-78
4. Fogel M, Altevogt P, Schirrmacher V. Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J Exp Med 1983; 157: 371-376
5. x expression defines invasive and metastatic properties of bladder carcinoma. Cancer 2002; 94: 673-685
6. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1996; 56: 5309-5318
7. Li XW, Ding YQ, Cai JJ, Yang SQ, An LB, Qiao DF. Studies on mechanism of Sialyl Lewis-X antigen in liver metastases of human colorectal carcinoma. World J Gastroenterol 2001; 7: 425-430
8. x in primary tumor and metastatic lymph nodes in human gastric cancer. J Surg Oncol 1996; 62: 171-176
9. Tang W, Mafune K, Nakata M, Konishi T, Kojima N, Mizuochi T, Makuuchi M. Association of Histochemical expression of Maackia amurensis leukoagglutinin-positive glycoconjugates with behavior of human gastric cancer. Histopathology 2003; 42: 239-245
10. Vierbuchen MJ, Fruechtnicht W, Brackrock S, Krause KT, Zienkiewicz TJ. Quantitative lectin histochemical and immunohistochemical studies on the occurrence of alpha(2,3)- and 22 alpha(2,6)-linked sialic acid residues in colorectal carcinomas. Relation to clinicopathologic features. Cancer 1995; 76: 727-735
11. Kohno N. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 1999; 46: 151-158
12. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 26 1988; 18: 203-216
13. Japanese Society of Biliary Surgery. General rules for surgical and pathological studies on cancer of biliary tract, 5th ed, Tokyo: Kanehara 2003
14. Sobin LH, Wittekind C. TNM classification of malignant tumors, 5th ed. New York: Wiley-Liss 1997
15. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nature Rev 2004; 4: 45-60
16. Adsay NV, Mrati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD, Sarkar PH, Hruban RH, Klimstra DS. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004; 28: 839-848
17. Gürbüz Y, Klöppel G. Differentiation pathways in duodenal ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas. Virch Arch 2004; 444: 536-541
18. Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Tsukui M, Tanaka Y, Matsubayashi H, Tsuchida T, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Tajima T, Makuuchi H. DF3 expression in human gallbladder carcinoma: significance for lymphatic invasion. Int J Oncol 2000; 16: 455-459
19. Luttges J, Feyerabend B, Buchelt T, Pacena M, Kloppel G. The mucin profile of non-invasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 2002; 26: 466-471
20. Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 1994; 106: 353-361
21. Cao Y, Karsten U. Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the epithelial mucin (MUC1) on tissue sections of adenolymphomas of the parotid (Warthin's tumours): role of epitope masking by glycans. Histochem Cell Viol 2001; 115: 349-356
22. Kim YS, Gum J, Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconjugate J 1996; 13: 693-707
23. Lloyd KO. The chemistry and immunohistochemistry of blood group A, B, H, and Lewis antigens: past, present and future. Glycoconjugate J 2000; 17: 531-541
24. Hakomori S. Possible functions of tumor-associated carbohydrate antigens. Curr Opin Immunol 1991; 3: 646-653
25. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1999; 1473: 67-95
26. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 1985; 54: 631-664
27. Tang W, Guo Q, Usuda M, Kokudo N, Seyama Y, Minagawa M, Sugawara Y, Nakata M, Kojima N, Makuuchi M. Histochemical expression of sialoglycoconjugates in carcinoma of the papilla of Vater. Hepato-gastroenterology 2005; 52: 67-71
28. Hiraga Y, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F, Kohno N. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Oncology 1998; 55: 307-319
29. Tanimoto T, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F, Kohno N. MUC1 expression in intramucosal colorectal neoplasms. Possible involvement in histogenesis and progression. Oncology 1999; 56: 223-231
30. Roder JD, Schneider PM, Stein HJ, Siewert JR. Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg 1995; 82: 1693-1696
31. Yoshida T, Matsumoto T, Shibata K, Yokoyama H, Morii Y, Sasaki A, Kitano S. Patterns of lymph node metastasis in carcinoma of the ampulla of Vater. Hepatogastroenterology 2000; 47: 880-883